Systematic literature review and meta-analysis of Clostridium septicum aortitis.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
08 2022
Historique:
received: 23 11 2021
accepted: 24 02 2022
pubmed: 1 4 2022
medline: 27 7 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Clostridium septicum bacteremia is often associated with occult malignancies (approximately 80%), especially of the right colon. Furthermore, inflammation of the aortic wall can rapidly lead to aneurysm induction through bacterial seeding into atheromatous lesions with consecutive life-threatening rupture. We summarize all published data on this rare and lethal disease to evaluate therapeutic approaches and give valid treatment recommendations because there are no guidelines. A systematic review of the literature was conducted screening EMBASE and MEDLINE databases following the PRISMA guidelines with search period from first description to August 25, 2021. There were 72 cases of C septicum aortitis reported in 64 publications. Endovascular aortic repair (EVAR) was performed in a minority of patients (n = 6) unfit for surgery but lacked long-term survivors. Antibiotic treatment was beneficial in a bridge to surgery concept, but up to now harbored a 6-month mortality rate of 100% (median overall survival, 0.5 months) when no additional aortic repair was performed. Open aortic repair was the only potential curative approach but was accompanied with a 90-day-mortality of 26.7% (4/15). Open aortic repair combined with perioperative antibiotic treatment should be offered to all patients as the only potentially curative approach. If applicable, resection of a coexisting colonic tumor should be performed after successful aortic repair. Alternatively, long-term antibiotic treatment can be offered to patients unfit for surgery in a palliative setting. Endovascular aortic repair has been performed on a minority of patients with a high risk for stent graft infection and should remain a salvage strategy when therapeutic pressure demands acute intervention in patients unfit for surgery.

Sections du résumé

BACKGROUND
Clostridium septicum bacteremia is often associated with occult malignancies (approximately 80%), especially of the right colon. Furthermore, inflammation of the aortic wall can rapidly lead to aneurysm induction through bacterial seeding into atheromatous lesions with consecutive life-threatening rupture. We summarize all published data on this rare and lethal disease to evaluate therapeutic approaches and give valid treatment recommendations because there are no guidelines.
METHODS
A systematic review of the literature was conducted screening EMBASE and MEDLINE databases following the PRISMA guidelines with search period from first description to August 25, 2021.
RESULTS
There were 72 cases of C septicum aortitis reported in 64 publications. Endovascular aortic repair (EVAR) was performed in a minority of patients (n = 6) unfit for surgery but lacked long-term survivors. Antibiotic treatment was beneficial in a bridge to surgery concept, but up to now harbored a 6-month mortality rate of 100% (median overall survival, 0.5 months) when no additional aortic repair was performed. Open aortic repair was the only potential curative approach but was accompanied with a 90-day-mortality of 26.7% (4/15).
CONCLUSIONS
Open aortic repair combined with perioperative antibiotic treatment should be offered to all patients as the only potentially curative approach. If applicable, resection of a coexisting colonic tumor should be performed after successful aortic repair. Alternatively, long-term antibiotic treatment can be offered to patients unfit for surgery in a palliative setting. Endovascular aortic repair has been performed on a minority of patients with a high risk for stent graft infection and should remain a salvage strategy when therapeutic pressure demands acute intervention in patients unfit for surgery.

Identifiants

pubmed: 35358668
pii: S0741-5214(22)00392-5
doi: 10.1016/j.jvs.2022.02.029
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Meta-Analysis Review Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-604.e1

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Patrick Kirchweger (P)

Department of Surgery, Ordensklinikum Linz, Linz, Austria; Johannes Kepler University Linz, Medical Faculty, Linz, Austria. Electronic address: patrick.kirchweger@ordensklinikum.at.

Helwig Wundsam (H)

Department of Surgery, Ordensklinikum Linz, Linz, Austria.

Felix Bosse (F)

Department of Surgery, Ordensklinikum Linz, Linz, Austria.

Antonia Fritz (A)

Department of Surgery, Ordensklinikum Linz, Linz, Austria.

Theresa Kratzer (T)

Department of Surgery, Ordensklinikum Linz, Linz, Austria.

Manfred Kalteis (M)

Department of Surgery, Ordensklinikum Linz, Linz, Austria.

Alexander Kupferthaler (A)

Johannes Kepler University Linz, Medical Faculty, Linz, Austria; Department of Diagnostic and Interventional Radiology, Ordensklinikum Linz, Linz, Austria.

Gernot Böhm (G)

Department of Diagnostic and Interventional Radiology, Ordensklinikum Linz, Linz, Austria.

Daniela Kern (D)

Department of Vascular Surgery, Brothers of Saint John of God, Linz, Austria.

Magdalena Forstner (M)

Department of Vascular Surgery, Brothers of Saint John of God, Linz, Austria.

Reinhold Huemer (R)

Department of Vascular Surgery, Brothers of Saint John of God, Linz, Austria.

Matthias Biebl (M)

Department of Surgery, Ordensklinikum Linz, Linz, Austria.

Reinhold Függer (R)

Department of Surgery, Ordensklinikum Linz, Linz, Austria; Johannes Kepler University Linz, Medical Faculty, Linz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH